CohBar, Inc. (CWBR) Q2 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Tuhura Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.533 -- 00:00:05.956 Good afternoon. My name is Ryan, and I will be your conference operator for today. 00:00:05.956 -- 00:00:11.160 At this time, I would like to welcome everyone to COBAR's second quarter 2022 00:00:11.160 -- 00:00:14.402 financial results conference call. 00:00:14.402 -- 00:00:19.184 All lines have been placed on mute to eliminate background noise. 00:00:19.184 -- 00:00:23.187 A question and answer session will follow the formal presentation. 00:00:23.187 -- 00:00:28.190 If anyone should require operator assistance during the conference, please press star 00:00:28.190 -- 00:00:31.030 zero on your telephone keypad. 00:00:31.030 -- 00:00:34.751 As a reminder, this conference is being recorded. 00:00:34.751 -- 00:00:37.372 Now, I would like to turn the call over to Ms. 00:00:37.372 -- 00:00:42.653 Jordan Tarazi, Director of Investor Relations at Cobar. 00:00:42.653 -- 00:00:44.753 Please go ahead. 00:00:44.753 -- 00:00:49.735 Thank you, Ryan, and thank you, everyone, for joining Cobar's second quarter 2022 financial 00:00:49.735 -- 00:00:53.196 results conference call. Joining me on today's call is Dr. 00:00:53.196 -- 00:00:58.993 Joe Surrett, Cobar's Chief Executive Officer, Jeff Beuno, Cobar's Chief Financial Officer, 00:00:58.993 -- 00:01:03.215 Dr. Nick Vlahakis, COBAR's Acting Chief Medical Officer, and Dr. 00:01:03.215 -- 00:01:06.656 Kent Greinstaff, Senior Vice President of Research. 00:01:06.656 -- 00:01:10.038 Following our collective remarks, we will conclude with Q&A. 00:01:10.038 -- 00:01:14.419 COBAR's financial results press release was issued earlier today and may be downloaded 00:01:14.419 -- 00:01:17.141 from our website at cobar.com. 00:01:17.141 -- 00:01:21.482 Before we begin, I'd like to take a moment to remind lis...